RecruitingPhase 3NCT06577519

Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

Efficacy and Safety of Vicagrel in Patients With With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI): a Multi-center, Randomized, Double-blind, Double-dummy , Parallel-controlled, Phase III Trial

Sponsor

Jiangsu vcare pharmaceutical technology co., LTD

Enrollment

1,000 participants

Start Date

Sep 6, 2024

Study Type

INTERVENTIONAL

Conditions

Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

Summary

This is a multi-center, randomized, double-blind, double-dummy, parallel-controled, phase III trial, aiming to evaluate the effectiveness and safety of long-term continuous administration of Vicagrel capsules in ACS patients undergoing PCI.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Clopidogrel and a drug called Vicagrel for people with acute coronary syndrome (acs) undergoing percutaneous coronary intervention (pci). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGVicagrel

Vicagrel loading followed by Maintenance dose

DRUGClopidogrel

Clopidogrel loading followed by Maintenance dose

Locations(1)

General Hospital of Northern Theater Command of Chinese PLA

Shenyang, Liaoning, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06577519

Related Trials

Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction

NCT069104361 location

Drug-Coated Balloon Primary PCI in ST-Segment Elevation Myocardial Infarction

NCT074364291 location